Navigation Links
NUCRYST Announces Senior Management Change
Date:4/3/2008

WAKEFIELD, MA, April 3 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS) announced today that Eliot M. Lurier will step down as Vice President Finance & Administration and Chief Financial Officer in order to take a position with another company in a field unrelated to any of NUCRYST's businesses, effective April 15, 2008. The Company has initiated a search for Mr. Lurier's successor.

"On behalf of the Board, I want to thank Eliot Lurier for his years of outstanding service and contributions to the growth and development of our business during his tenure at NUCRYST, and we wish him the very best for the future," said Thomas E. Gardner, Chairman and Chief Executive Officer.

About NUCRYST Pharmaceuticals

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith & Nephew plc sell a range of advanced wound care products under their Acticoat(TM) trade mark. Acticoat(TM) products incorporate NUCRYST's SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101 for use in medical devices and as an active pharmaceutical ingredient.

Acticoat(TM) is a trademark of
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NUCRYST Pharmaceuticals announces year-end results
2. NUCRYST Pharmaceuticals announces 2007 third quarter results
3. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
4. NUCRYST and Smith & Nephew Revise Agreements
5. Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008
6. Medical Records Institute Announces New TEPR Award for EMRs Best Meeting Medicolegal Requirements
7. East Ridge Retirement Village Announces Enhancement Plan
8. QED International Associates Announces Changes to the HealthShares(TM) Cardio Devices Index
9. The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
10. Selective Insurance Group Announces Officer Appointments
11. Somanetics Announces Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Diabetics at Greater Risk of Developing Dry Skin Infection 5818 1Diabetics at Greater Risk of Developing Dry Skin Infection 5818 2Diabetics at Greater Risk of Developing Dry Skin Infection 5818 3Diabetics at Greater Risk of Developing Dry Skin Infection 5818 4PDI Inc to Hold Third Quarter 2009 Financial Results Conference Call on Thursday November 5 2009 5816 1PDI Inc to Hold Third Quarter 2009 Financial Results Conference Call on Thursday November 5 2009 5816 2CVS Caremarks MinuteClinic and Allina Hospitals 26amp 3B Clinics Form Strategic Partnership 5814 1CVS Caremarks MinuteClinic and Allina Hospitals 26amp 3B Clinics Form Strategic Partnership 5814 2CVS Caremarks MinuteClinic and Allina Hospitals 26amp 3B Clinics Form Strategic Partnership 5814 3CVS Caremarks MinuteClinic and Allina Hospitals 26amp 3B Clinics Form Strategic Partnership 5814 4